Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Basic Clin Pharmacol Toxicol ; 114(6): 476-84, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24345272

ABSTRACT

Renal thioredoxin reductase-1 (TrxR-1) activity is stimulated at lead doses lower than that necessary to inhibit δ-aminolevulinate dehydratase activity (δ-ALA-D), which is a classical early biomarker of lead effects. Thus, we hypothesized that the activity of TrxR-1 could be a more sensitive early indicator of lead effects than is δ-ALA-D. To evaluate this hypothesis, we assessed the blood and renal TrxR-1 activity and its gene expression along with biomarkers of oxidative damage, antioxidant enzyme activities and biomarkers of lead exposure in rats acutely exposed to lead. A histopathological analysis was performed to verify renal damage. The increase in renal TrxR-1 activity paralleled the increase in the blood and renal lead levels at 6, 24 and 48 hr after the exposure to 25 mg/kg lead acetate (p < 0.05), whereas its expression was increased 24 and 48 hr after exposure. These effects were not accompanied by oxidative or tissue damage in the kidneys. Blood TrxR-1 activity was not affected by lead exposure (up to 25 mg/kg). Erythrocyte δ-ALA-D activity was inhibited 6 hr after the exposure to 25 mg/kg lead acetate (p < 0.05) but recovered thereafter. Renal δ-ALA-D activity decreased 24 and 48 hr after the exposure to 25 mg/kg lead acetate. There were no changes in any parameters at lead acetate doses <25 mg/kg. Our results indicate that blood TrxR-1 activity is not a suitable indicator of lead effects. In contrast, the increase in renal TrxR-1 expression and activity is implicated in the early events of lead exposure, most likely as a protective cellular mechanism against lead toxicity.


Subject(s)
Cytosol/enzymology , Kidney/drug effects , Lead/toxicity , Thioredoxin Reductase 1/metabolism , Animals , Erythrocytes/enzymology , Intracellular Signaling Peptides and Proteins/physiology , Kelch-Like ECH-Associated Protein 1 , Kidney/enzymology , Kidney/pathology , Lead/pharmacokinetics , Male , Porphobilinogen Synthase/metabolism , Rats , Rats, Wistar , Thioredoxin Reductase 1/genetics
2.
Lipids Health Dis ; 11: 79, 2012 Jun 21.
Article in English | MEDLINE | ID: mdl-22721254

ABSTRACT

BACKGROUND: There is a relationship among hypercholesterolemia, oxidative stress and inflammation in the atherogenesis. Thus, the objective of the present study was to assess paraoxonase (PON1), superoxide dismutase (SOD) and thioredoxin reductase (TrxR-1) activities and their relationship with lipids, oxidative stress and inflammation in subjects with different low density lipoprotein-cholesterol (LDL) levels. METHODS: Serum lipids, highly sensitive C-reactive protein (hs-CRP), lipid and protein oxidation, oxidized LDL (LDLox) and LDLox autoantibodies (LDLoxAB) levels and enzymes activities were measured in a total of 116 subjects that were divided into the following groups according to their LDL levels: low-LDL group (LDL < 100 mg/dL, n = 23), intermediate-LDL group (LDL 100-160 mg/dL, n = 50) and high-LDL group (LDL > 160 mg/dL, n = 43). RESULTS: The LDLox and hs-CRP levels increased in the high-LDL group (2.7- and 3.7- fold, respectively), whereas the intermediate and high-LDL groups had higher LDLoxAB (2.2- and 3.1-fold) when compared to low-LDL group (p < 0.05). Similarly, SOD activity, the atherogenic index (AI) and protein oxidation were also higher in the intermediate (1.3-, 1.3- and 1.2-fold) and high-LDL (1.6-, 2.3- and 1.6-fold) groups when compared to the low-LDL group (p < 0.05). Lipid oxidation and SOD/TrxR-1 ratio increased only in the high-LDL group (1.3- and 1.6-fold) when compared to the low-LDL group (p < 0.05). The SOD/TrxR-1 ratio was positively correlated to TBARS (r = 0.23, p < 0.05), LDLox (r = 0.18, p < 0.05), LDLoxAB (r = 0.21, p < 0.05), LDL (r = 0.19, p < 0.05) and AI (r = 0.22, p < 0.05). PON1 and TrxR-1 activities were similar among groups. CONCLUSIONS: Some oxidative events initiate when LDL levels are clinically acceptable. Moreover, hypercholesterolemic patients have an imbalance in SOD and TrxR-1 activities that is positively associated to LDL oxidation.


Subject(s)
Hypercholesterolemia/blood , Hypercholesterolemia/enzymology , Lipoproteins, LDL/blood , Superoxide Dismutase/blood , Thioredoxin Reductase 1/blood , Adult , Aged , Aryldialkylphosphatase/blood , Autoantibodies/blood , Biomarkers/blood , C-Reactive Protein/metabolism , Female , Humans , Hypercholesterolemia/immunology , Inflammation Mediators/blood , Lipid Peroxidation , Lipoproteins, LDL/immunology , Male , Middle Aged , Oxidative Stress
3.
J Investig Med ; 59(4): 649-54, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21307777

ABSTRACT

AIM: Hyperglycemia in diabetes mellitus (DM) may be one of the most important factors responsible for the development of oxidative stress, which promotes the main complications in DM patients. Therefore, this study evaluated if the hyperglycemia could be related to oxidative stress biomarkers, lipid profile, and renal function in type 2 diabetes patients without clinic complications. METHODS: Plasmatic malondialdehyde (MDA), serum protein carbonyl (PCO), serum creatinine levels, microalbuminuria, glycated hemoglobin, and lipid profile were analyzed in 37 type 2 diabetic patients and 25 subjects with no diabetes. RESULTS: Serum creatinine levels were within the reference values, but microalbuminuria presented increased levels in all the patients compared with controls (P < 0.05) and above of the reference values. The MDA, PCO, low-density lipoprotein, and triglyceride levels showed positive correlation with microalbuminuria levels. Moreover, glycated hemoglobin presented positive correlation with MDA, PCO, and microalbuminuria levels. CONCLUSIONS: The hyperglycemia could be responsible for the increase of the microalbuminuria levels and for the oxidation process in lipids and proteins in DM patients. Therefore, we suggested that the microvascular lesion is a direct consequence from hyperglycemia and an indirect one from the increased oxidative stress. Malondialdehyde and protein carbonyl levels could be suggested as additional biochemical evaluation to verify tissue damage in type 2 DM patients.


Subject(s)
Albuminuria/pathology , Diabetes Mellitus, Type 2/pathology , Oxidative Stress/physiology , Albuminuria/etiology , Albuminuria/urine , Biomarkers/urine , Clinical Chemistry Tests , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/urine , Female , Humans , Hyperglycemia/etiology , Hyperglycemia/pathology , Hyperglycemia/urine , Male , Middle Aged
4.
Arch Toxicol ; 85(9): 1151-7, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21286687

ABSTRACT

Aim of the study was to find out whether consumption of quercetin (QC), an abundant flavonoid in the human diet, protects against DNA damage caused by exposure to organic mercury. Therefore, rats were treated orally with methylmercury (MeHg) and the flavonoid with doses that reflect the human exposure. The animals received MeHg (30 µg/kg/bw/day), QC (0.5-50 mg/kg/bw/day), or combinations of both over 45 days. Subsequently, the glutathione levels (GSH) and the activities of glutathione peroxidase (GPx) and catalase (CAT) were determined, and DNA damage was measured in hepatocytes and peripheral leukocytes in single cell gel electrophoresis assays. MeHg decreased the concentration of GSH and the activity of GPx by 17 and 12%, respectively and caused DNA damage to liver and blood cells, while with QC no such effects were seen. When the flavonoid was given in combination with MeHg, the intermediate and the highest concentrations (5.0 and 50.0 mg/kg/bw/day) were found to cause DNA protection; DNA migration was reduced by 54 and 65% in the hepatocytes and by 27 and 36% in the leukocytes; furthermore, the reduction in GSH and GPx levels caused by MeHg treatment was restored. In summary, our results indicate that consumption of QC-rich foods may protect Hg-exposed humans against the adverse health effects of the metal.


Subject(s)
Antioxidants/pharmacology , DNA Damage/drug effects , Methylmercury Compounds/toxicity , Mutagens/toxicity , Oxidative Stress/drug effects , Quercetin/pharmacology , Animals , Catalase/metabolism , Comet Assay , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Hepatocytes/drug effects , Hepatocytes/enzymology , Hepatocytes/metabolism , Leukocytes/drug effects , Leukocytes/enzymology , Leukocytes/metabolism , Liver/drug effects , Liver/enzymology , Liver/metabolism , Male , Methylmercury Compounds/blood , Methylmercury Compounds/pharmacokinetics , Mutagens/pharmacokinetics , Rats , Rats, Wistar
5.
Ecotoxicol Environ Saf ; 74(3): 487-93, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20970192

ABSTRACT

The present study evaluates a possible protective effect of fish oil against oxidative damage promoted by methylmercury (MeHg) in sub-chronically exposed rats. Reduced glutathione peroxidase and catalase enzyme activity and reduced glutathione levels were observed in MeHg-exposed animals compared to controls. Methylmercury exposure was also associated with DNA damage. Administration of fish oil to the methylmercury-exposed animals did not ameliorate enzyme activity or glutathione levels. On the other hand, a significant DNA protective effect (about 30%) was observed with fish oil treatment. There were no differences in the total mercury concentration in rat liver, kidney, heart or brain after MeHg administration with or without fish oil co-administration. Histopathological analyses showed a significant leukocyte infiltration in rat tissues after MeHg exposure, but this effect was significantly reduced after co-administration of fish oil. Taken together, our findings demonstrate oxidative damage even after low-level MeHg exposure and the protective effect of fish oil. This protection seems not to be related to antioxidant defenses or mercury re-distribution in rat tissues. It is probably due to the anti-inflammatory effects of fish oil.


Subject(s)
Antioxidants/pharmacology , Fish Oils/pharmacology , Methylmercury Compounds/toxicity , Oxidative Stress/drug effects , Animals , Brain/drug effects , Brain/metabolism , Brain/pathology , Catalase/metabolism , DNA Damage/drug effects , Glutathione Peroxidase/metabolism , Kidney/metabolism , Liver/metabolism , Male , Mercury/metabolism , Mercury/toxicity , Myocardium/metabolism , Myocardium/pathology , Rats , Rats, Wistar
6.
Basic Clin Pharmacol Toxicol ; 106(2): 95-9, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19874286

ABSTRACT

In this study, we examined the effects of low levels and sub-chronic exposure to methylmercury (MeHg) on butyrylcholinesterase (BuChE) activity in rats. Moreover, we examined the relationship between BuChE activity and oxidative stress biomarkers [delta-aminolevulinic acid dehydratase (delta-ALA-D) and malondialdehyde levels (MDA)] in the same animals. Rats were separated into three groups (eight animals per group): (Group I) received water by gavage; (Group II) received MeHg (30 microg/kg/day) by gavage; (Group III) received MeHg (100 microg/kg/day). The time of exposure was 90 days. BuChE and ALA-D activities were measured in serum and blood, respectively; whereas MDA levels were measured in plasma. We found BuChE and ALA-D activities decreased in groups II and III compared to the control group. Moreover, we found an interesting negative correlation between plasmatic BuChE activity and MDA (r = -0.85; p < 0.01) and a positive correlation between plasmatic BuChE activity and ALA-D activities (r = 0.78; p < 0.01), thus suggesting a possible relationship between oxidative damage promoted by MeHg exposure and the decrease of BuChE activity. In conclusion, long-term exposure to low doses of MeHg decreases plasmatic BuChE activity. Moreover, the decrease in the enzyme is strongly correlated with the oxidative stress promoted by the metal exposure. This preliminary finding highlights a possible mechanism for MeHg to reduce BuChE activity in plasma. Additionally, this enzyme could be an auxiliary biomarker on the evaluation of MeHg exposure.


Subject(s)
Butyrylcholinesterase/drug effects , Methylmercury Compounds/toxicity , Animals , Biomarkers/metabolism , Butyrylcholinesterase/blood , Butyrylcholinesterase/metabolism , Dose-Response Relationship, Drug , Male , Malondialdehyde/metabolism , Methylmercury Compounds/administration & dosage , Oxidative Stress/drug effects , Porphobilinogen Synthase/drug effects , Porphobilinogen Synthase/metabolism , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...